UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 125

Sortiert nach

A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic hepatitis C: Results from a large US multi-center observational study

PloS one, 2018-08, Vol.13 (8), p.e0196908-e0196908

2018

Volltextzugriff (PDF)

Incorporating Patient-Reported Outcomes Into Hepatitis C Virus Treatment Studies

Clinical gastroenterology and hepatology, 2014-08, Vol.12 (8), p.1360-1362

Evon, Donna M., PhD

2014

Volltextzugriff (PDF)

“If I Get Cured, My Whole Quality of Life Will Change”: Patients’ Anticipated and Actualized Benefits Following Cure from Chronic Hepatitis C

Digestive diseases and sciences, 2022-01, Vol.67 (1), p.100-120

2022

Volltextzugriff (PDF)

Tangible Resources for Multidisciplinary Treatment of Patients With Nonalcoholic Fatty Liver Disease

The American journal of gastroenterology, 2023-03, Vol.118 (3), p.389-393

2023

Volltextzugriff (PDF)

Symptoms of Liver Disease During Tenofovir Therapy With or Without Peginterferon: Results from the Hepatitis B Research Network Immune Active Trial

Digestive diseases and sciences, 2023-12, Vol.68 (12), p.4499-4510

2023

Volltextzugriff (PDF)

A Randomized Controlled Trial of an Integrated Alcohol Reduction Intervention in Patients With Hepatitis C Infection

Hepatology (Baltimore, Md.), 2020-06, Vol.71 (6), p.1894-1909

2020

Volltextzugriff (PDF)

Early Survivorship After Liver Transplantation: A Qualitative Study Identifying Challenges in Recovery From the Patient and Caregiver Perspective

Liver transplantation, 2022-03, Vol.28 (3), p.422-436

2022

Volltextzugriff (PDF)

Symptoms and functioning improve after chronic hepatitis C cure as assessed by the Memorial Symptom Assessment Scale and PROMIS measures

Journal of viral hepatitis, 2021-10, Vol.28 (10), p.1491-1495

2021

Volltextzugriff (PDF)

Scoping review of values elicitation tools for treatment decisions in hepatocellular carcinoma

BMC gastroenterology, 2024-02, Vol.24 (1), p.90-10, Article 90

2024

Volltextzugriff (PDF)

Pharmacist attitudes and provision of harm reduction services in North Carolina: an exploratory study

Harm reduction journal, 2021-07, Vol.18 (1), p.1-11, Article 70

2021

Volltextzugriff (PDF)

Active coping, resilience, post-traumatic growth, and psychiatric symptoms among early and late liver transplant survivors

Liver transplantation, 2023-03, Vol.29 (3), p.290-306

2023

Volltextzugriff (PDF)

What Survivorship Means to Liver Transplant Recipients: Qualitative Groundwork for a Survivorship Conceptual Model

Liver transplantation, 2021-10, Vol.27 (10), p.1454-1467

2021

Volltextzugriff (PDF)

Psychiatric diagnoses are common after liver transplantation and are associated with increased health care utilization and patient financial burden

Liver transplantation, 2024-06

2024

Volltextzugriff (PDF)

Patient-reported symptoms during and after direct-acting antiviral therapies for chronic hepatitis C: The PROP UP study

Journal of hepatology, 2019-09, Vol.71 (3), p.486-497

2019

Volltextzugriff (PDF)

Sustainable and equivalent improvements in symptoms and functional well‐being following viral cure from ledipasvir/sofosbuvir versus elbasvir/grazoprevir for chronic hepatitis C infection: Findings from the randomized PRIORITIZE trial

Journal of viral hepatitis, 2022-09, Vol.29 (9), p.795-806

2022

Volltextzugriff (PDF)

Fatigue before, during and after antiviral therapy of chronic hepatitis C: Results from the Virahep-C study

Journal of hepatology, 2012-11, Vol.57 (5), p.946-952

2012

Volltextzugriff (PDF)

A Novel Patient-Reported Outcome-Based Evaluation (PROBE) of Quality of Life in Patients With Inflammatory Bowel Disease

The American journal of gastroenterology, 2019-04, Vol.114 (4), p.640-647

2019

Volltextzugriff (PDF)

Hepatitis delta testing trends in a US national cohort: An analysis of patient and provider-level predictive factors

Hepatology communications, 2024-05, Vol.8 (5)

2024

Volltextzugriff (PDF)

Exploring the impact of brief training on student pharmacists' naloxone communication skills

PEC innovation, 2023-12, Vol.3, p.100196-100196, Article 100196

2023

Volltextzugriff (PDF)

What Liver Transplant Recipients Want in a Smartphone Intervention to Enhance Recovery: Prototype for the LiveRight Transplant App

Liver transplantation, 2021-04, Vol.27 (4), p.584-589

2021

Volltextzugriff (PDF)

Patient Knowledge, Beliefs and Barriers to Hepatitis B Care: Results of a Multicenter, Multiethnic Patient Survey

Digestive diseases and sciences, 2021-02, Vol.66 (2), p.434-441

2021

Volltextzugriff (PDF)

Factors associated with perceived ease of access to syringes in Appalachian North Carolina

The Journal of rural health, 2023, Vol.39 (1), p.212-222

2023

Volltextzugriff (PDF)

A Randomized Controlled Trial of an Integrated Care Intervention to Increase Eligibility for Chronic Hepatitis C Treatment

The American journal of gastroenterology, 2011-10, Vol.106 (10), p.1777-1786

2011

Volltextzugriff (PDF)

Medication Non-adherence in a Prospective, Multi-center Cohort Treated with Hepatitis C Direct-Acting Antivirals

Journal of general internal medicine : JGIM, 2020-04, Vol.35 (4), p.1011-1020

2020

Volltextzugriff (PDF)

Addressing the opioid epidemic through community pharmacy engagement: Study protocol for a randomized controlled trial

Contemporary clinical trials, 2022-10, Vol.121, p.106920-106920, Article 106920

2022

Volltextzugriff (PDF)

1 – 25 von 125

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(122)
Mit Volltextzugriff
(111)

Publikationsform

Sprache

Englisch
(125)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(82)
Life Sciences & Biomedicine
(81)
Humans
(72)
Gastroenterology & Hepatology
(52)
Male
(50)
Female
(49)
Adult
(42)
Middle Aged
(34)
Hepatitis C
(29)
Hepatitis
(24)
Infectious Diseases
(22)
Hepatitis C, Chronic - Drug Therapy
(21)
Patients
(21)
Antiviral Agents - Therapeutic Use
(18)
Quality Of Life
(17)
Hepatology
(16)
Aged
(15)
Antiviral Agents
(15)
Biological And Medical Sciences
(15)
Hepatitis C Virus
(15)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic hepatitis C: Results from a large US multi-center observational study

Incorporating Patient-Reported Outcomes Into Hepatitis C Virus Treatment Studies

“If I Get Cured, My Whole Quality of Life Will Change”: Patients’ Anticipated and Actualized Benefits Following Cure from Chronic Hepatitis C

Tangible Resources for Multidisciplinary Treatment of Patients With Nonalcoholic Fatty Liver Disease

Symptoms of Liver Disease During Tenofovir Therapy With or Without Peginterferon: Results from the Hepatitis B Research Network Immune Active Trial

A Randomized Controlled Trial of an Integrated Alcohol Reduction Intervention in Patients With Hepatitis C Infection

Early Survivorship After Liver Transplantation: A Qualitative Study Identifying Challenges in Recovery From the Patient and Caregiver Perspective

Symptoms and functioning improve after chronic hepatitis C cure as assessed by the Memorial Symptom Assessment Scale and PROMIS measures

Scoping review of values elicitation tools for treatment decisions in hepatocellular carcinoma

Pharmacist attitudes and provision of harm reduction services in North Carolina: an exploratory study

Active coping, resilience, post-traumatic growth, and psychiatric symptoms among early and late liver transplant survivors

What Survivorship Means to Liver Transplant Recipients: Qualitative Groundwork for a Survivorship Conceptual Model

Psychiatric diagnoses are common after liver transplantation and are associated with increased health care utilization and patient financial burden

Patient-reported symptoms during and after direct-acting antiviral therapies for chronic hepatitis C: The PROP UP study

Sustainable and equivalent improvements in symptoms and functional well‐being following viral cure from ledipasvir/sofosbuvir versus elbasvir/grazoprevir for chronic hepatitis C infection: Findings from the randomized PRIORITIZE trial

Fatigue before, during and after antiviral therapy of chronic hepatitis C: Results from the Virahep-C study

A Novel Patient-Reported Outcome-Based Evaluation (PROBE) of Quality of Life in Patients With Inflammatory Bowel Disease

Hepatitis delta testing trends in a US national cohort: An analysis of patient and provider-level predictive factors

Exploring the impact of brief training on student pharmacists' naloxone communication skills

What Liver Transplant Recipients Want in a Smartphone Intervention to Enhance Recovery: Prototype for the LiveRight Transplant App

Patient Knowledge, Beliefs and Barriers to Hepatitis B Care: Results of a Multicenter, Multiethnic Patient Survey

Factors associated with perceived ease of access to syringes in Appalachian North Carolina

A Randomized Controlled Trial of an Integrated Care Intervention to Increase Eligibility for Chronic Hepatitis C Treatment

Medication Non-adherence in a Prospective, Multi-center Cohort Treated with Hepatitis C Direct-Acting Antivirals

Addressing the opioid epidemic through community pharmacy engagement: Study protocol for a randomized controlled trial

Suchergebnisse filtern